Cargando…
Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples
BACKGROUND: Detailed molecular evaluation of cytology and limited tissue samples is increasingly becoming the standard for cancer care. Reproducible and accurate diagnostic approaches with reduced demands on cellularity are an ongoing unmet need. This study evaluated the performance of a 92-gene ass...
Autores principales: | Brachtel, Elena F., Operaña, Theresa N., Sullivan, Peggy S., Kerr, Sarah E., Cherkis, Karen A., Schroeder, Brock E., Dry, Sarah M., Schnabel, Catherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053644/ https://www.ncbi.nlm.nih.gov/pubmed/27034010 http://dx.doi.org/10.18632/oncotarget.8449 |
Ejemplares similares
-
OTHR-16. MOLECULAR PROFILING USING THE 92-GENE ASSAY FOR TUMOR CLASSIFICATION OF BRAIN METASTASES
por: Brenner, Andrew, et al.
Publicado: (2019) -
Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma
por: Overman, Michael J., et al.
Publicado: (2016) -
DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms †
por: Vielh, Philippe, et al.
Publicado: (2020) -
Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B
por: Fei, Xifeng, et al.
Publicado: (2022) -
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay
por: Raghav, Kanwal, et al.
Publicado: (2020)